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Background:  Heart failure (HF) can occur in patients with preserved ejection fraction (HFpEF). While some studies suggest the presence of subtle 
contractile dysfunction in HFpEF patients, whether systolic dysfunction progresses over time is unclear.
Methods:  Among a community cohort of validated incident HF patients in Olmsted County, Minnesota, we obtained all ejection fractions (EF) 
assessed by echocardiography from the time of HF diagnosis until death or last follow-up. We ran mixed effects models that fit a linear regression 
line for each person using serial EF data, and compiled results to obtain estimates of the change in EF over time. Results are presented for patients 
with preserved (≥50%, HFpEF) and reduced (<50%, HFrEF) EF at HF diagnosis.
Results:  Among 1279 HF patients (48.5% male, mean age 74.7 years, mean follow-up 5.2 years), 581 (45.4%) had HFpEF. The number of 
echocardiograms per person ranged from 1 to 39 (median 2). In HFpEF, EF decreased over time with greater decreases noted in those who 
were older at diagnosis (age*time to EF p=0.019, Table). Conversely, EF increased or remained stable in HFrEF, but this varied by age and sex 
(age*sex*time to EF p=0.023). During follow-up, 38.5% of patients with HFpEF at diagnosis had a subsequent EF<50%, and 38.7% of those with 
HFrEF had an EF≥50%.
Conclusions:  These data suggest that progressive contractile dysfunction may contribute to the pathophysiology of HFpEF in some patients. 
Prospective studies are needed to better examine this phenomenon. 
Baseline EF Sex Age Est. Change in EF (%) at 5 yrs (95% CI)
HFpEF Both <70 -2.68(-4.90, -0.45)
70-79 -5.14(-7.74, -2.54)
≥80 -6.50(-9.09, -3.91)
HFrEF F <70 5.95(2.98, 8.92)
70-79 7.68(4.32, 11.04)
≥ 80 6.95(1.55, 12.35)
M 70-79 4.30( 2.15, 6.44)
70-79 2.41(-0.58, 5.40)
≥ 80 -0.22(-5.39, 4.94)
